US Stock MarketDetailed Quotes

Revelation Biosciences (REVB)

Watchlist
  • 0.8999
  • -0.0001-0.01%
Close Jan 15 16:00 ET
  • 0.9171
  • +0.0172+1.91%
Pre 05:35 ET
5.33MMarket Cap0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revelation Biosciences (REVB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.14%1.94M
-2.42%2.46M
10.14%2.09M
-7.87%7.98M
-24.59%1.75M
-35.32%1.8M
30.49%2.52M
17.43%1.9M
-20.32%8.66M
90.91%2.33M
Selling and administrative expenses
5.64%1.02M
1.40%1.14M
4.36%1.24M
-1.88%4.43M
-9.28%1.15M
-14.28%965.71K
10.13%1.13M
8.22%1.18M
-17.79%4.51M
44.12%1.27M
-General and administrative expense
5.64%1.02M
1.40%1.14M
4.36%1.24M
-1.88%4.43M
-9.28%1.15M
-14.28%965.71K
10.13%1.13M
8.22%1.18M
-17.79%4.51M
44.12%1.27M
Research and development costs
11.06%922.86K
-5.52%1.32M
19.68%858.83K
-14.40%3.55M
-42.88%605.5K
-49.68%830.98K
53.41%1.39M
36.61%717.58K
-22.90%4.15M
211.79%1.06M
Operating profit
-8.14%-1.94M
2.42%-2.46M
-10.14%-2.09M
7.87%-7.98M
24.59%-1.75M
35.32%-1.8M
-30.49%-2.52M
-17.43%-1.9M
20.32%-8.66M
-90.91%-2.33M
Net non-operating interest income expense
Other net income (expense)
108.05%35.84K
100.29%16.85K
105.63%43.9K
-182.74%-7.06M
-77.10%28.17K
-397.54%-444.88K
-1,310.13%-5.87M
-110.02%-779.3K
24,316.25%8.54M
122.99K
Gain on sale of security
-89.89%611
-99.00%44
-97.93%1.42K
-99.02%81.44K
-96.25%2.56K
-93.47%6.04K
-98.96%4.42K
-99.12%68.43K
--8.33M
--68.2K
Other non- operating income (expenses)
107.81%35.22K
100.29%16.8K
105.01%42.49K
-3,543.76%-7.14M
-53.25%25.61K
-891.64%-450.92K
-9,628.96%-5.87M
-2,585.48%-847.72K
493.42%207.47K
--54.79K
Income before tax
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Income tax
Net income
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Net income continuous Operations
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Minority interest income
Net income attributable to the parent company
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Preferred stock dividends
Other preferred stock dividends
2.77M
3.18M
0
0
Net income attributable to common stockholders
-108.65%-4.68M
32.94%-5.63M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Basic earnings per share
95.59%-1.77
97.15%-21.03
94.64%-6.33
-938.86%-263.04
96.93%-14.94
91.58%-40.15
-164.01%-738.81
-105.41%-118.11
99.65%-25.32
80.88%-487.08
Diluted earnings per share
95.59%-1.77
97.15%-21.03
94.64%-6.33
-938.86%-263.04
96.93%-14.94
91.58%-40.15
-164.01%-738.81
-106.64%-118.11
99.65%-25.32
80.88%-487.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.14%1.94M-2.42%2.46M10.14%2.09M-7.87%7.98M-24.59%1.75M-35.32%1.8M30.49%2.52M17.43%1.9M-20.32%8.66M90.91%2.33M
Selling and administrative expenses 5.64%1.02M1.40%1.14M4.36%1.24M-1.88%4.43M-9.28%1.15M-14.28%965.71K10.13%1.13M8.22%1.18M-17.79%4.51M44.12%1.27M
-General and administrative expense 5.64%1.02M1.40%1.14M4.36%1.24M-1.88%4.43M-9.28%1.15M-14.28%965.71K10.13%1.13M8.22%1.18M-17.79%4.51M44.12%1.27M
Research and development costs 11.06%922.86K-5.52%1.32M19.68%858.83K-14.40%3.55M-42.88%605.5K-49.68%830.98K53.41%1.39M36.61%717.58K-22.90%4.15M211.79%1.06M
Operating profit -8.14%-1.94M2.42%-2.46M-10.14%-2.09M7.87%-7.98M24.59%-1.75M35.32%-1.8M-30.49%-2.52M-17.43%-1.9M20.32%-8.66M-90.91%-2.33M
Net non-operating interest income expense
Other net income (expense) 108.05%35.84K100.29%16.85K105.63%43.9K-182.74%-7.06M-77.10%28.17K-397.54%-444.88K-1,310.13%-5.87M-110.02%-779.3K24,316.25%8.54M122.99K
Gain on sale of security -89.89%611-99.00%44-97.93%1.42K-99.02%81.44K-96.25%2.56K-93.47%6.04K-98.96%4.42K-99.12%68.43K--8.33M--68.2K
Other non- operating income (expenses) 107.81%35.22K100.29%16.8K105.01%42.49K-3,543.76%-7.14M-53.25%25.61K-891.64%-450.92K-9,628.96%-5.87M-2,585.48%-847.72K493.42%207.47K--54.79K
Income before tax 14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Income tax
Net income 14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Net income continuous Operations 14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Minority interest income
Net income attributable to the parent company 14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Preferred stock dividends
Other preferred stock dividends 2.77M3.18M00
Net income attributable to common stockholders -108.65%-4.68M32.94%-5.63M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Basic earnings per share 95.59%-1.7797.15%-21.0394.64%-6.33-938.86%-263.0496.93%-14.9491.58%-40.15-164.01%-738.81-105.41%-118.1199.65%-25.3280.88%-487.08
Diluted earnings per share 95.59%-1.7797.15%-21.0394.64%-6.33-938.86%-263.0496.93%-14.9491.58%-40.15-164.01%-738.81-106.64%-118.1199.65%-25.3280.88%-487.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -